Characteristic | Survivor, N=148 | Non-survivor/ITU/NIV, N=39 | P value |
Age (18+), years | 55 (44–71) | 66 (60–76) | <0.001 |
Sex | 0.7 | ||
Male | 79 (53) | 22 (56) | |
Female | 69 (47) | 17 (44) | |
PCR proven disease | 0.6 | ||
Proven | 111 (75) | 31 (79) | |
Suspected | 37 (25) | 8 (21) | |
Status at time of consent | 0.010 | ||
Inpatient | 119 (80) | 38 (97) | |
Outpatient | 29 (20) | 1 (2.6) | |
Diabetes status | 0.3 | ||
No | 115 (78) | 34 (87) | |
T1DM | 3 (2.0) | 1 (2.6) | |
T2DM | 30 (20) | 4 (10) | |
Heart disease | 34 (23) | 12 (31) | 0.3 |
Chronic lung disease | 26 (18) | 20 (51) | <0.001 |
Severe liver disease | 3 (2.0) | 2 (5.1) | 0.3 |
Severe kidney impairment (eGFR <30 or dialysis) | 16 (11) | 6 (15) | 0.4 |
Hypertension | 37 (25) | 15 (38) | 0.10 |
HIV status | 1 (0.7) | 1 (2.6) | 0.4 |
Non-white ethnicity | 20 (16) | 5 (15) | 0.9 |
Median (IQR); n (%).
Wilcoxon rank sum test; Pearson’s χ2 test; Fisher’s exact test.
eGFR, estimated glomerular filtration rate; ITU, Intensive Care admission; NIV, non-invasive ventilation; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.